Catalog |
name |
Description |
price |
R-M-1920 |
Thalidomide-O-PEG4-t-butyl ester |
Thalidomide-O-PEG4-t-butyl ester, is synthesized intermediate that incorporates the Thalidomide based cereblon ligand and PEG space used in PROTAC technology. |
price> |
R-M-1921 |
Thalidomide-O-PEG5-Tosyl,Cas:2414905-34-1 |
Thalidomide-O-PEG5-Tosyl is a molecule that incorporates the Thalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology. It is reactive with nucleophiles such as amine, hydroxy containing molecules. |
price> |
R-M-1922 |
4-Fluoro-thalidomide,Cas:835616-60-9 |
4-Fluoro-thalidomide is the Thalidomide-based Cereblon ligand used in the recruitment of CRBN protein. It can be connected to the ligand for IRAK4 protein by a linker to form PROTAC IRAK4 degrader-1 (HY-129966). |
price> |
R-M-1923 |
Pomalidomide-PEG3-NH-Boc |
Pomalidomide-PEG3-NH-Boc is synthesized intermediate that incorporates the Pomalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology. |
price> |
R-M-1924 |
Pomalidomide-PEG5-Azide |
Pomalidomide-PEG5-Azide is a PROTAC linker that incorporates the Pomalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology.Azide enable click chemistry with Alkyne, DBCO or BCN molecules. |
price> |
R-M-1925 |
D-Biotin-PEG6-Thalidomide,Cas:2144775-48-2 |
D-Biotin-PEG6-Thalidomide is a cereblon affinity probe for PROTAC and targeted protein degradation research. It can be used in cereblon (CRBN) binding and displacement assays for protein degrader validation experiments, CRBN ligand discovery, competition analyses, or where enrichment of CRBN complexes is required. The hydrophilic PEG spacer increases the solubility of a compound in aqueous media. |
price> |
R-M-1926 |
D-Amino-PEG6-Thalidomide TFA salt |
D-amino-peg6-thalidomide TFA salt can be applied to protac drug research & discovery . |
price> |
R-M-1928 |
(S, R, S)-AHPC-pentanoic-acid,Cas:2172819-74-6 |
(S, R, S)-AHPC-pentanoic-acid is a PROTAC linker that incorporate an E3 ligase ligand with a linker to empower PROTAC drug research & discovery. It can react with amine containing molecules. |
price> |
R-M-1929 |
(S, R, S)-AHPC-PEG2-acid,Cas:2172820-09-4 |
(S, R, S)-AHPC-PEG2-acid is a syntheticPROTAC linker molecule that incorporates an E3 ligase ligand with a PEG linker to empower PROTAC drug research & discovery. The hydrophilic PEG spacer increases the solubility of a compound in aqueous media. |
price> |
R-M-1930 |
(S, R, S)-AHPC-PEG3-acid,Cas:2140807-42-5 |
(S, R, S)-AHPC-PEG3-acid is a PROTAC linker that incorporate an E3 ligase ligand with a PEG3 linker to empower PROTAC drug research & discovery. |
price> |